Literature DB >> 23234317

The rise of the biosimilar.

Mark McCamish, Gillian Woollett.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23234317     DOI: 10.1586/ecp.12.60

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  3 in total

1.  Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey.

Authors:  Stephen R Chapman; Raymond W Fitzpatrick; Mohammed I Aladul
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

2.  What drives the prescribing of growth hormone preparations in England? Prices versus patient preferences.

Authors:  Stephen R Chapman; Raymond W Fitzpatrick; Mohammed I Aladul
Journal:  BMJ Open       Date:  2017-04-11       Impact factor: 2.692

3.  Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.

Authors:  Alain Beck; Janice M Reichert
Journal:  MAbs       Date:  2013-07-24       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.